In addition, we compared the therapeutic effects of paeoniflorin with escitalopram, which is commonly used in the clinic to treat patients with IFN-α-induced depression, and studied the anti-neuroinflammatory and antidepressant effects of both substances. The gene discussed is IFNA2; the disease is depressive symptom measurement.